Janet Tewhill has been promoted from vice president of client services to senior vice president/chief operating officer at Alere Medical (Reno, Nevada) Additionally, Neil Dickman, PhD., has joined the company as vice president of sales and client services. Dickman most recently was vice president, strategic initiatives, for United Behavioral Health, a subsidiary of United Healthcare. Alere develops remote monitoring services and provides nursing assessment and patient education.

John Lewis has joined Eklin Medical Systems (Sunnyvale, California) as vice president of worldwide sales. Lewis has more than 20 years' experience in sales force creation and management with such companies as Beckman Instruments, Molecular Dynamics, Alara and Celera Genomics. Eklin Medical Systems focuses on digital radiography and image management for the veterinary market.

Kirk Malloy, PhD, has been promoted to vice president of Illumina (San Diego). Malloy joined Illumina in 2002 as senior director of customer solutions, and later added quality assurance to his responsibilities. Illumina develops systems enabling the large-scale analysis of genetic variation and function; its flagship product is the BeadArray technology.

Shawl Lobree has been appointed vice president of marketing for R2 Technology (Sunnyvale, California). Lobree formerly was with Siemens Medical Solutions and co-founded the women's health web site Imaginis.com. Three other persons also recently joined the R2 management team: Denise Gottfried, vice president, regulatory, clinical, medical and quality, comes to R2 from TekTeam, where she was president. Brad Freeman, vice president of global supply chain, service and information services, joins the company from Siemens Medical Solutions, where he was vice president, strategic purchasing and chief information officer for its Ultrasound Division. And Stephen Geisheker, director of customer service, comes to R2 from Plexus Software, where he served as director of customer support and operations. R2 Technology develops computer-aided detection (CAD) systems; its ImageChecker product was the first CAD system approved by the FDA for use with mammography.

D. Bruce Pattison has been appointed president and chief operating officer of Saliva Diagnostic Systems (New York). Pattison has been working closely with the company as a consultant over the past five months. Most recently, Pattison negotiated the sale of Arrow International's drug delivery business to Johnson & Johnson (J&J) and then joined J&J as executive director of drug delivery. Saliva Diagnostic Systems manufactures a rapid point-of-care testing device for infectious diseases, as well as oral fluid specimen collection devices using a patented volume adequacy indicator for drugs of abuse testing and other clinical uses.

Matthew Plavan has been appointed CFO of ThermoGenesis (Rancho Cordova, California). Plavan succeeds Renee Ruecker, who sought reduced working hours for family reasons and who will become director of Securities and Exchange Commission reporting, a new position created to accommodate Sarbanes-Oxley compliance requirements. Plavan comes to ThermoGenesis from his most recent position as CFO of StrionAir. ThermoGenesis develops enabling technologies for cell therapeutics.

Kevin Gould has been promoted to chief operating officer for Tyco Healthcare (Mansfield, Massachusetts). Gould also will retain his current responsibilities as group president of Tyco Healthcare North America. Tyco Healthcare, a business of Tyco International, manufactures disposable medical supplies, monitoring equipment, medical instruments and bulk analgesic pharmaceuticals, sold under such names as Auto Suture, Kendall, Mallinckrodt, Nellcor, Puritan Bennett, United States Surgical, Valleylab and others.

Michael Carrel has been named chief operating officer and CFO for Vital Images (Minneapolis, Minnesota). He has been interim CFO at the company since January. Vital Images is a provider of visualization software solutions for use in disease-screening applications, clinical diagnosis and therapy planning.

Vikram Jog has joined XDx (South San Francisco, California) as CFO. Most recently, Jog served as vice president of finance for Celera Genomics and Celera Diagnostics. XDx, a molecular diagnostics company, has developed a new method for non-invasively monitoring the immune system by measuring gene expression in a patients' peripheral blood.